Reduced platelet glutamate uptake in Parkinson's disease

Journal of Neural Transmission

Volumn 106, Issue 7-8, 1999, Pages 685-692

  Ferrarese, C ^b   Zoia, C ^c   Pecora, N ^c   Piolti, R ^c   Frigo, M ^c   Bianchi, G ^c   Sala, G ^c   Begni, B ^c   Riva, R ^c   Frattola, L ^a  

^a Pro Juventute Foundation   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c NONE

Author keywords

Excitotoxicity; Glutamate; Parkinson's disease; Platelets

Indexed keywords

GLUTAMIC ACID; MITOCHONDRIAL ENZYME;

AMINO ACID TRANSPORT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; ENERGY METABOLISM; HUMAN; HUMAN CELL; PARKINSON DISEASE; PARKINSONISM; PATIENT; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SUBSTANTIA NIGRA; THROMBOCYTE;

ANALYSIS OF VARIANCE; BLOOD PLATELETS; CASE-CONTROL STUDIES; ENERGY METABOLISM; FEMALE; GLUTAMIC ACID; HUMANS; MALE; PARKINSON DISEASE;

EID: 0032801005     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050189     Document Type: Article

References (31)

1. 14C-dopamine in platelets: evidence for a generalized defect in Parkinsons's disease. Neurology 25: 1-9
2. Beal MF (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 31: 119-130
3. Benecke R, Strumper P, Weiss H (1993) Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson plus syndromes. Brain 116:1451-1463
4. Fahn S, Cohen G (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 32: 804-812
5. Fahn S, Elton RL (1987) The Members of the UPDRS development committee, Unified Parkinson's disease rating scale. In: Fahn S, Marsden D, Calne D (eds) Recent developments in Parkinson's disease. MacMillan, London, pp 153-163
6. Ferrarese C, Pecora N, Frigo M, Appollonio I, Frattola L (1993) Assessment of reliability and biological significance of glutamate levels in cerebrospinal fluid. Ann Neurol 33:316-319
7. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-Mental State": a pratical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198
8. Haas HR, Chir B, Nasirian F, Nakano K, Ward D, Pay M, Hill R, Shults C (1995) Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann Neurol 37: 714-722
9. Hattori N, Tanaka M, Ozawa T, Mizuno Y (1991) Immunohistochemical studies on Complexes I, II, III and IV of mithocondria in Parkinson's disease. Ann Neurol 30: 563-571
10. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427-442
11. Krige D, Carroll MT, Cooper JM, Marsden CD, Schapira AHV (1992) Platelet mithocondrial function in Parkinson's disease. Ann Neurol 32: 782-788
12. Lin C-LG, Bristol LA, Lin J, Dykes-Hoberg M, Crawford T, Clawson L, Rothstein JD (1998) Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20: 589-602
13. Lipton SA, Rosenberg PA (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330: 613-622
14. Mangano RM, Schwarcz R (1981a) The human platelet as a model for the glutamatergic neuron: platelet uptake of L-glutamate. J Neurochem 36: 1067-1076
15. Mangano RM, Schwarcz R (1981b) Platelet glutamate and aspartate uptake in Huntington's disease. J Neurochem 37(4): 1072-1074
16. Mann VB, Cooper JM, Krige D, Daniel SE, Shapira AHV, Marsden CD (1992) Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 115: 333-342
17. Masliah E, Alford M, DeTeresa R, Mallory M, Hansen L (1996) Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol 40: 759-766
18. Meyer T, Speer A, Meyer B, Sitte W, Külher G, Ludolph AC (1996) The glial glutamate transporter complementary DNA in patients with amyotrophic lateral sclerosis. Ann Neurol 40: 456-459
19. Mizuno Y, Matuda S, Yoshino H, Mori H, Hattoru N, Ikebe SI (1994) An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann Neurol 35: 204-210
20. Murphy S, Munoz S, Parry-Billings M, Newsholme E (1992) Amino acid metabolism during platelet storage for transfusion. Br J Haematol 81: 585-590
21. Parker WD, Boyson SJ, Parks JK (1989) Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 26: 719-723
22. Parker WD, Mahr NJ, Parks JK, Hughes D, Young DA, Cullum CM (1994) Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology 44: 1086-1090
23. Pellerin L, Magistretti P (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA 91: 10625-10629
24. 3H] dopamine uptake by platelet transport chain in idiopathic Parkinson's disease. Life Sci 3: 1753-1757
25. Rothstein JD, Martin LJ, Kunel RW (1992) Decreased glutamate transport by brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 326: 1464-1468
26. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kunel RW (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38: 73-84
27. Shoffner JM, Watts RL, Juncos JL, Torroni A, Wallace DC (1991) Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol 30: 332-339
28. Shults CW, Nasirian F, Ward DM, Nakano K, Pay M, Hill LR, Haas RH (1995) Carbidopa/levodopa and sclegiline do not affect platelet mitochondrial function in early parkinsonism. Neurology 45: 344-348
29. Swerdlow R, Parks JK, Miller SW, Tuttle JB, Trimmer PA, Shecan JP, Bennett JP, Davis RE, Parker WD (1996) Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 40: 663-671
30. Volterra A,Trotti D, Tromba C, Floridi S, Racagni G (1994) Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J Neurosci 14: 2924-2932
31. Yoshino H, Nakagawa-Hattori Y, Kondo T, Mizuno Y (1992) Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease. J Neural Transm 41:27-34